Expertise in
8
conditions

Jae-hwan Y. Lee

Yongin, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
Yongin, KR 

Overview

Jae-hwan Lee practices practicing medicine in Yongin, Republic of Korea.

Lee is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Peripheral Artery Disease, Coronary Heart Disease, Heart Attack, Angioplasty, and Atherectomy.

They are actively involved in clinical research, co-authoring 199 peer reviewed articles and participating in 6 clinical trials.

Locations

Yongin, Republic of Korea
Other Locations
Daejeon, Republic of Korea
Gyeonggi-do, Republic of Korea
Jungnam, Republic of Korea
Sejong, Republic of Korea
Seoul, Republic of Korea
Anseong, Republic of Korea
Santyoku, Republic of Korea
Chungbuk, Republic of Korea
Yangsan, Republic of Korea
Cheongju-si, Republic of Korea
Puch'on, Republic of Korea
R&D Center, Ansan, 425839, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Enrollment Status: Recruiting
Publish Date: April 05, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Study for Evaluation of Safety and Efficacy of Transcatheter RF Ablation System (TIRA Catheter) to Treat Hypertrophic Obstructive Cardiomyopathy : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
The Study for Evaluation of Safety and Efficacy of Transcatheter RF Ablation System (TIRA Catheter) to Treat Hypertrophic Obstructive Cardiomyopathy : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
Enrollment Status: Terminated
Publish Date: April 16, 2025
Intervention Type: Device
Study Phase: Not Applicable
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Enrollment Status: Unknown
Publish Date: April 09, 2025
Intervention Type: Other
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
Perfusion CT Registry
Perfusion CT Registry
Enrollment Status: Completed
Publish Date: March 22, 2023
A Prospective, Multicenter, Single Arm, Post-Market Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Femoropopliteal Arteries
A Prospective, Multicenter, Single Arm, Post-Market Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: July 17, 2020
View 5 Less Clinical Trials

198 Total Publications

Lacticaseibacillus paracasei HP7 Attenuates Helicobacter pylori Activity and Improves Upper Gastrointestinal Symptoms: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial.
Lacticaseibacillus paracasei HP7 Attenuates Helicobacter pylori Activity and Improves Upper Gastrointestinal Symptoms: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial.
Journal: Journal of medicinal food
Published: August 31, 2026

Frequently Asked Questions about Jae-hwan Y. Lee

Is Jae-hwan Y. Lee a top-rated expert for Angioplasty?

MediFind is an objective health platform that identifies experts based on real-world data. Jae-hwan Y. Lee is classified as an Distinguished expert for Angioplasty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jae-hwan Y. Lee participate in research or clinical trials?

Yes. Jae-hwan Y. Lee has published 198 articles and abstracts on conditions like Angioplasty. You can view a list of Jae-hwan Y. Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lee's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile